Metoclopramid Laropharm (Metoclopramide Hydrochloride Monohydrate)

Metoclopramide works by blocking dopamine D2 receptors in the brain’s chemoreceptor trigger zone, which reduces the signal that triggers nausea and vomiting. In the gastrointestinal tract, dopamine blockade increases acetylcholine release, promoting coordinated muscular contractions that speed gastric emptying.

The appropriate dose of Metoclopramid Laropharm is determined by the prescribing clinician based on the patient’s condition, age, renal function and other individual factors. Healthcare professionals set the regimen according to current clinical guidelines and patient needs.

The pregnancy category for metoclopramide is not definitively established, and safety data are limited. It should be used during pregnancy or while breastfeeding only if the potential benefit justifies any potential risk to the fetus or infant, and under close medical supervision.

To order Metoclopramid Laropharm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoclopramide differs from many antiemetics such as 5‑HT3 antagonists by targeting dopamine receptors and also offering pro‑kinetic activity that speeds gastric emptying. This dual action makes it useful for conditions like gastroparesis, whereas drugs like ondansetron focus solely on serotonin pathways and lack pro‑kinetic effects.

Metoclopramid Laropharm should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct light, and ensure the container is tightly closed to maintain product stability.

Metoclopramid Laropharm is taken orally, usually with or without food as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious adverse effects include extrapyramidal symptoms such as dystonia or akathisia, tardive dyskinesia with long‑term use, neuroleptic malignant syndrome, severe allergic reactions, and hyperprolactinemia that can cause hormonal disturbances. Patients should seek immediate medical attention if they experience muscle rigidity, high fever, or uncontrolled movements.

Metoclopramid Laropharm should be avoided in individuals with known hypersensitivity to metoclopramide, in patients with pheochromocytoma, seizure disorders, or severe depression with suicidal thoughts, and in those taking other potent dopamine antagonists unless specifically directed by a physician.